These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 25868977)

  • 21. Phenotypic, structural, and ultrastructural analysis of triple-negative breast cancer cell lines and breast cancer stem cell subpopulation.
    Moreira MP; Brayner FA; Alves LC; Cassali GD; Silva LM
    Eur Biophys J; 2019 Oct; 48(7):673-684. PubMed ID: 31485678
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Tricostantin A inhibits self-renewal of breast cancer stem cells in vitro].
    Peng L; Li FX; Shao WF; Xiong JB
    Nan Fang Yi Ke Da Xue Xue Bao; 2013 Oct; 33(10):1421-6. PubMed ID: 24144739
    [TBL] [Abstract][Full Text] [Related]  

  • 23. ALDH/CD44 identifies uniquely tumorigenic cancer stem cells in salivary gland mucoepidermoid carcinomas.
    Adams A; Warner K; Pearson AT; Zhang Z; Kim HS; Mochizuki D; Basura G; Helman J; Mantesso A; Castilho RM; Wicha MS; Nör JE
    Oncotarget; 2015 Sep; 6(29):26633-50. PubMed ID: 26449187
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hypoxia regulates stemness of breast cancer MDA-MB-231 cells.
    Xie J; Xiao Y; Zhu XY; Ning ZY; Xu HF; Wu HM
    Med Oncol; 2016 May; 33(5):42. PubMed ID: 27038472
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Isolation and characterization of tumorigenic extrahepatic cholangiocarcinoma cells with stem cell-like properties.
    Wang M; Xiao J; Shen M; Yahong Y; Tian R; Zhu F; Jiang J; Du Z; Hu J; Liu W; Qin R
    Int J Cancer; 2011 Jan; 128(1):72-81. PubMed ID: 20232394
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antitumor activity of Cetuximab in combination with Ixabepilone on triple negative breast cancer stem cells.
    Tanei T; Choi DS; Rodriguez AA; Liang DH; Dobrolecki L; Ghosh M; Landis MD; Chang JC
    Breast Cancer Res; 2016 Jan; 18(1):6. PubMed ID: 26757880
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cleaved CD44 intracellular domain supports activation of stemness factors and promotes tumorigenesis of breast cancer.
    Cho Y; Lee HW; Kang HG; Kim HY; Kim SJ; Chun KH
    Oncotarget; 2015 Apr; 6(11):8709-21. PubMed ID: 25909162
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of Tumor Recurrence After Resection of Highly- and Poorly-Metastatic Triple-negative Breast Cancer in Orthotopic Nude-Mouse Models.
    Yano S; Takehara K; Kishimoto H; Tazawa H; Urata Y; Kagawa S; Fujiwara T; Bouvet M; Hoffman RM
    Anticancer Res; 2017 Jan; 37(1):57-60. PubMed ID: 28011473
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CD44+/CD24- breast cancer cells exhibit enhanced invasive properties: an early step necessary for metastasis.
    Sheridan C; Kishimoto H; Fuchs RK; Mehrotra S; Bhat-Nakshatri P; Turner CH; Goulet R; Badve S; Nakshatri H
    Breast Cancer Res; 2006; 8(5):R59. PubMed ID: 17062128
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characteristic genes in luminal subtype breast tumors with CD44+CD24-/low gene expression signature.
    Tsunoda Y; Sakamoto M; Sawada T; Sasaki A; Yamamoto G; Tachikawa T
    Oncology; 2011; 81(5-6):336-44. PubMed ID: 22237177
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adipose-derived stem cells and cancer cells fuse to generate cancer stem cell-like cells with increased tumorigenicity.
    Chan YW; So C; Yau KL; Chiu KC; Wang X; Chan FL; Tsang SY
    J Cell Physiol; 2020 Oct; 235(10):6794-6807. PubMed ID: 31994190
    [TBL] [Abstract][Full Text] [Related]  

  • 32. STAT3 signaling is activated preferentially in tumor-initiating cells in claudin-low models of human breast cancer.
    Wei W; Tweardy DJ; Zhang M; Zhang X; Landua J; Petrovic I; Bu W; Roarty K; Hilsenbeck SG; Rosen JM; Lewis MT
    Stem Cells; 2014 Oct; 32(10):2571-82. PubMed ID: 24891218
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A novel mouse model of human breast cancer stem-like cells with high CD44+CD24-/lower phenotype metastasis to human bone.
    Ling LJ; Wang S; Liu XA; Shen EC; Ding Q; Lu C; Xu J; Cao QH; Zhu HQ; Wang F
    Chin Med J (Engl); 2008 Oct; 121(20):1980-6. PubMed ID: 19080260
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HES1-mediated inhibition of Notch1 signaling by a Gemini vitamin D analog leads to decreased CD44(+)/CD24(-/low) tumor-initiating subpopulation in basal-like breast cancer.
    So JY; Wahler J; Das Gupta S; Salerno DM; Maehr H; Uskokovic M; Suh N
    J Steroid Biochem Mol Biol; 2015 Apr; 148():111-21. PubMed ID: 25541438
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Semi-quantitative evaluation of CD44(+) /CD24(-) tumor cell distribution in breast cancer tissue using a newly developed fluorescence immunohistochemical staining method.
    Kai M; Onishi H; Souzaki M; Tanaka H; Kubo M; Tanaka M; Katano M
    Cancer Sci; 2011 Dec; 102(12):2132-8. PubMed ID: 21838786
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Repression of mammosphere formation of human breast cancer cells by soy isoflavone genistein and blueberry polyphenolic acids suggests diet-mediated targeting of cancer stem-like/progenitor cells.
    Montales MT; Rahal OM; Kang J; Rogers TJ; Prior RL; Wu X; Simmen RC
    Carcinogenesis; 2012 Mar; 33(3):652-60. PubMed ID: 22219179
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical implications of Ezrin and CD44 co‑expression in breast cancer.
    Ma L; Jiang T
    Oncol Rep; 2013 Oct; 30(4):1899-905. PubMed ID: 23900701
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential in vivo tumorigenicity of distinct subpopulations from a luminal-like breast cancer xenograft.
    Skrbo N; Hjortland GO; Kristian A; Holm R; Nord S; Prasmickaite L; Engebraaten O; Mælandsmo GM; Sørlie T; Andersen K
    PLoS One; 2014; 9(11):e113278. PubMed ID: 25419568
    [TBL] [Abstract][Full Text] [Related]  

  • 39. VEGF drives cancer-initiating stem cells through VEGFR-2/Stat3 signaling to upregulate Myc and Sox2.
    Zhao D; Pan C; Sun J; Gilbert C; Drews-Elger K; Azzam DJ; Picon-Ruiz M; Kim M; Ullmer W; El-Ashry D; Creighton CJ; Slingerland JM
    Oncogene; 2015 Jun; 34(24):3107-19. PubMed ID: 25151964
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The anti-diabetic drug metformin suppresses the metastasis-associated protein CD24 in MDA-MB-468 triple-negative breast cancer cells.
    Vazquez-Martin A; Oliveras-Ferraros C; Cufí S; Del Barco S; Martin-Castillo B; Lopez-Bonet E; Menendez JA
    Oncol Rep; 2011 Jan; 25(1):135-40. PubMed ID: 21109968
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.